Skip to main content
. 2021 Mar 10;26(4):288–e541. doi: 10.1002/onco.13712
Completion Did not fully accrue; study terminated before completion
Investigator's Assessment Study prematurely terminated because of the COVID‐19, with only modest activity in a small number of patients.